Hospital care and pneumococcal immunisation policy

Improving surveillance of the impact of influenza and its prevention in Canada.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2005

Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.

Vaccine·2003

Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

The Japanese experience with vaccinating schoolchildren against influenza.

The New England journal of medicine·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Healthcare professionals' perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States.

Expert review of vaccines·2026

A Nationwide Review of the Utilization of Rapid Antigen Testing for Group A Streptococcus.

Cureus·2026

Homozygous familial hypercholesterolemia, experience with Evinacumab treatment in two Mexican pediatric patients: case report.

Frontiers in genetics·2026

Psychiatric and medical profiles of children receiving health protection measures in a tertiary care facility: A five-year analysis.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Predictors of parental stress in families of children with neurodevelopmental disabilities.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH.

Frontiers in pediatrics·2026

Related Experiment Videos

Hospital care and pneumococcal immunisation policy

Related Concept Videos

Improving surveillance of the impact of influenza and its prevention in Canada.

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.

Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.

Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective.

The Japanese experience with vaccinating schoolchildren against influenza.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Healthcare professionals' perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States.

A Nationwide Review of the Utilization of Rapid Antigen Testing for Group A Streptococcus.

Homozygous familial hypercholesterolemia, experience with Evinacumab treatment in two Mexican pediatric patients: case report.

Psychiatric and medical profiles of children receiving health protection measures in a tertiary care facility: A five-year analysis.

Predictors of parental stress in families of children with neurodevelopmental disabilities.

Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH.

Related Experiment Videos

Hospital care and pneumococcal immunisation policy

Related Concept Videos

Related Articles